July 6, 2020 — The San Antonio Partnership for Precision Therapeutics (SAPPT) received a $97,141 donation for critical COVID-19 medical research from the San Antonio Area Foundation.
SAPPT was established in October 2019 to leverage the unique bioscience capabilities of four prominent San Antonio research institutions — Southwest Research Institute, Texas Biomedical Research Institute, San Antonio and The University of Texas at San Antonio.
In early May, SAPPT issued a request for funding for COVID-19 research and development to accelerate their collaborative efforts to understand, treat and prevent COVID-19.
The Area Foundation responded to the call. The Area Foundation has a long history of helping in the event of a crisis, emergency or natural disaster.
“Accelerating the race for a COVID-19 vaccine through collaborative research is the pathway to saving lives,” stated Marjie M. French, CEO of the San Antonio Area Foundation. “We are delighted to provide this funding for such an important initiative.”
The San Antonio Area Foundation has served as the sole, designated community foundation for the San Antonio area for over half a century, growing to become one of the top 20 foundations in the nation based on asset size. The Area Foundation helps donors achieve their charitable goals, managing more than 500 charitable funds valued at over $1 billion in assets. Coordinating efforts with numerous area nonprofits, the Area Foundation serves as a collaborative leader, connecting donors to address key community issues and investing in the future. Since 1964, over $500 million in scholarships and grants have been awarded to enhance the quality of life in our region. Learn more at saafdn.org.
For more information, visit Pharmaceutical Development or contact Lisa Peña at +1 210 522 2046, Communications Department, Southwest Research Institute, 6220 Culebra Road, San Antonio, TX 78238-5166.